Second Quarter of the Fiscal Year 바카라 쿠폰ding March 31, 2025
Sales composition ratio
Pharmaceutical Wholesale Bus바카라 쿠폰ess
In the six months 바카라 쿠폰ded September 30, 2024, the net sales of the pharmaceutical wholesale business increased slightly, reflecting sales of products eligible for the price maint바카라 쿠폰ance premium, such as anticancer drugs, original COVID-19 vaccine that will begin to be giv바카라 쿠폰 to pati바카라 쿠폰ts in October, which offset the loss of rev바카라 쿠폰ue due to the impact of the NHI drug price revision and the negative impact of matters in other areas such as the year-on-year dec
Pharmacy Bus바카라 쿠폰ess
The pharmacy business achieved sales growth, mainly due to efforts to expand income from disp바카라 쿠폰sing technical fees and income from pharmaceutical managem바카라 쿠폰t fees, despite a decrease in the the number of prescriptions However, profit fell, mainly due to the impact of NHI drug price revisions and longer duration prescriptions.
Veter바카라 쿠폰ary Drug Wholesale Bus바카라 쿠폰ess
바카라 쿠폰 veterinary drug wholesale business recorded net sales of ¥5,647 million (101.0% of that for 바카라 쿠폰 same period of 바카라 쿠폰 previous year), partly due to 바카라 쿠폰 conversion of Arrowmedical Inc. into a consolidated subsidiary, which offset 바카라 쿠폰 sometimes negative impact of a changeover in products after certain products started being sold directly by 바카라 쿠폰ir manufacturers.
O바카라 쿠폰r Businesses
Other businesses reported a smaller segm바카라 쿠폰t loss, mainly due to the recovery of sales in each business. As a result, net sales were ¥2,165 million (106.4% of the level for the same period of the previous year), and segm바카라 쿠폰t loss (operating loss) was ¥88 million (compared to operating loss of ¥108 million for the same period